Tema Neuroscience And Etf Performance
| MNTL Etf | 26.18 0.06 0.23% |
The entity has a beta of 0.94, which indicates possible diversification benefits within a given portfolio. Tema Neuroscience returns are very sensitive to returns on the market. As the market goes up or down, Tema Neuroscience is expected to follow.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Tema Neuroscience and has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Tema Neuroscience is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors. ...more
Tema |
Tema Neuroscience Relative Risk vs. Return Landscape
If you would invest 2,678 in Tema Neuroscience and on September 2, 2024 and sell it today you would lose (60.00) from holding Tema Neuroscience and or give up 2.24% of portfolio value over 90 days. Tema Neuroscience and is currently does not generate positive expected returns and assumes 1.1103% risk (volatility on return distribution) over the 90 days horizon. In different words, 9% of etfs are less volatile than Tema, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Tema Neuroscience Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tema Neuroscience's investment risk. Standard deviation is the most common way to measure market volatility of etfs, such as Tema Neuroscience and, and traders can use it to determine the average amount a Tema Neuroscience's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0264
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MNTL |
Estimated Market Risk
| 1.11 actual daily | 9 91% of assets are more volatile |
Expected Return
| -0.03 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Tema Neuroscience is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tema Neuroscience by adding Tema Neuroscience to a well-diversified portfolio.
About Tema Neuroscience Performance
By examining Tema Neuroscience's fundamental ratios, stakeholders can obtain critical insights into Tema Neuroscience's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Tema Neuroscience is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Tema Neuroscience is entity of United States. It is traded as Etf on NASDAQ exchange.| Tema Neuroscience generated a negative expected return over the last 90 days |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Tema Neuroscience and. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
The market value of Tema Neuroscience is measured differently than its book value, which is the value of Tema that is recorded on the company's balance sheet. Investors also form their own opinion of Tema Neuroscience's value that differs from its market value or its book value, called intrinsic value, which is Tema Neuroscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tema Neuroscience's market value can be influenced by many factors that don't directly affect Tema Neuroscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tema Neuroscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tema Neuroscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tema Neuroscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.